Efficacy and Safety of Two Doses of Formoterol Fumarate MDI (PT005) in Patients With Stable Chronic Obstructive Pulmonary Disease (COPD), Compared to Foradil® Aerolizer® as an Active Control

Clinical trial NCT01043601 · WITHDRAWN

Trial details

NCT number

NCT01043601

Sponsor

Pearl Therapeutics, Inc.

Status

WITHDRAWN

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2010-07-01

Primary completion

2011-04-01

Enrollment

0

View on ClinicalTrials.gov